Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chul Ahn
Daniel Ahn

Showing results (571-580 of 593) with videos related to

Pageof 60
Sort By:
Cancer|November 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 studyCody Eslinger, Daniel Walden, Alexandra Krivonos, et al.
JCO Precision Oncology|November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo ClinicOudai Sahwan, Fares Jamal, Rish Pai, et al.
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Nature Communications|December 27, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapyChan Yeong Kim, Dong Jin Park, Beung Chul Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung CancerDavid E Gerber, William C Putnam, Farjana J Fattah, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 2025
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and RecurrenceReetesh K Pai, Cody Eslinger, Kenneth Lee, et al.
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective StudyPedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Pageof 60

Showing results (571-580 of 593) with videos related to

Sort By:
Pageof 60
Cancer|November 22, 2025
Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 studyCody Eslinger, Daniel Walden, Alexandra Krivonos, et al.
JCO Precision Oncology|November 20, 2025
Immune Checkpoint Inhibitors for Mismatch Repair-Deficient Gastroesophageal Adenocarcinoma: Outcomes and Feasibility of Nonoperative Management at Mayo ClinicOudai Sahwan, Fares Jamal, Rish Pai, et al.
Clinical and Translational Gastroenterology|October 8, 2021
Clinical Impact of Pathogenic Germline Variants in Pancreatic Cancer: Results From a Multicenter, Prospective, Universal Genetic Testing StudyPedro L S Uson, N Jewel Samadder, Douglas Riegert-Johnson, et al.
Cancer|September 14, 2016
Biliary cancer: Utility of next-generation sequencing for clinical managementMilind Javle, Tanios Bekaii-Saab, Apurva Jain, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2021
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell CarcinomaRaquibul Hannan, Osama Mohamad, Alberto Diaz de Leon, et al.
Nature Communications|December 27, 2024
A conserved pilin from uncultured gut bacterial clade TANB77 enhances cancer immunotherapyChan Yeong Kim, Dong Jin Park, Beung Chul Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 28, 2020
Concentration-dependent Early Antivascular and Antitumor Effects of Itraconazole in Non-Small Cell Lung CancerDavid E Gerber, William C Putnam, Farjana J Fattah, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 2025
Quantitative Analysis of Rectal Cancer Biopsies With the Digital Pathology Segmentation Algorithm QuantCRC Associates With Therapy Response and RecurrenceReetesh K Pai, Cody Eslinger, Kenneth Lee, et al.
Cancers|May 25, 2024
Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal AdenocarcinomaAakash Desai, Alexander H Xiao, Daheui Choi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective StudyPedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Pageof 60